I distinctly remember one of the sells about going to the nasdaq was that we would have more liquidity. Biocryst has more liquidity in a day than we do in 2 months.
Seriously prana biotech managed a dual listing, they had a smaller market cap than biota prior to the recent upswing.
They've also been able to raise capital consistently with the dual listing and have far more liquidity than us.
Shame biota shame.
BTA Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held